Bank of America’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
AC
GS
VCM
CBU
Bank of America's TMCI Position: Q1 2026 in Review
Bank of America increased its Treace Medical Concepts (TMCI) stake by 39% in Q1 2026, buying an estimated $1.79M and bringing the position to 3,214,293 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3586.
Bank of America first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.89M in Q4 2022. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.
- Bank of America held 3,214,293 shares of Treace Medical Concepts worth $4.31M as of Q1 2026.
- Bank of America bought 900,071 Treace Medical Concepts shares in Q1 2026, an estimated $1.79M.
- Treace Medical Concepts made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3586 holding.
- Bank of America first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
- Bank of America's Treace Medical Concepts position peaked at $5.89M in Q4 2022.
- 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.